THERAMetrics holding AG (SIX: TMX) announces the financial results for the quarter and nine months ended September 30, 2014. Donnerstag, 13. November 2014 - 21:06
Stans, Switzerland, November 13, 2014
For the nine months ended September 30, 2014 the Company and its subsidiaries (the “Group”) generated revenues of EUR 11.7 million and EBITDA of negative EUR 5.5 million.
The Group has made significant progress with its turnaround plan, particularly in the area of cost reductions. The full impact of these reductions will be seen starting in Q4 2014. With the cost-reduction phase of the turnaround plan nearing completion, and with the success of its recent capital increase, the Company will now shift its focus to business development and revenue growth in its three principle business lines:
- CRO, with particular emphasis on Phase I and II clinical trials
- Drug rescuing and repurposing via its proprietary DRR2.0 tool
- IMP, a business which the Company believes has solid growth potential
In addition, the Company is actively working on licensing out its Intellectual Properties.
About Therametrics holding AG
Therametrics holding AG is a global tech-based Contract Research & Development Organisation dedicated to providing a full range of technological solutions through the entire value chain of drug discovery and development. The company is listed on the SIX Swiss Exchange under the symbol TMX and is headquartered in Stans, Switzerland.
For further information please contact
Raffaele Petrone
THERAMetrics holding AG
Investor and External Relations
T. +41 (0)44 723 59 59
F. +41 (0)44 726 90 12
investor@therametrics.com
www.therametrics.com
Media relation:
Rossana Del Forno
Global Consult
areacomunicazione@globalconsultsrl.com
Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
Files:
pdf eng